Copyright
©The Author(s) 2021.
World J Cardiol. Apr 26, 2021; 13(4): 82-94
Published online Apr 26, 2021. doi: 10.4330/wjc.v13.i4.82
Published online Apr 26, 2021. doi: 10.4330/wjc.v13.i4.82
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram.
- Citation: Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94
- URL: https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i4.82